<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2016-06-15</publicationDate>
    
        <volume>12</volume>
        <issue>Spl.Edn.1</issue>

 
    <startPage>19</startPage>
    <endPage>24</endPage>

	 
      <doi>10.13005/bbra/1600</doi>
        <publisherRecordId>12539</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Stem Cell-Based Therapy in Human Neurodegenerative Diseases</title>

    <authors>
	 


      <author>
       <name>Esmaeel Ebrahimi</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Seyed Ahmad Hosseini</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Saeed Shirali</name>

		
	<affiliationId>3</affiliationId>
      </author>
    

	 


      <author>
       <name>Mostafa Cheshmposh</name>

		
	<affiliationId>1</affiliationId>
      </author>
    


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliationName>
    

		
		<affiliationName affiliationId="2">Nutrition and Metabolic Diseases Research Center ,Ahvaz Jundishapur, University of Medical Sciences, Ahvaz, Iran.</affiliationName>
    
		
		<affiliationName affiliationId="3">Hyperlipidemia Research Center, Department of Laboratory Sciences, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliationName>
    
		
		
		
	  </affiliationsList>






    <abstract language="eng">Cell therapy is a procedure in which replace healthy cells to unhealthy and
damaged cells. Due to lack of suitable methods for treatment of neurological diseases,
patients have problems enormous. The lack of neurotransmitters and neurotrophic factors
are main causes of these diseases. During the past decade, a variety of cells such as
embryonic stem cells, fetal-derived neuronal cells, and induced pluripotent stem cells
(iPSCs) have been used for compensate neurological deficits and treatment of these
disorders in a variety of animal models. Several studies have been conducted to produce
nerve cells by different types of stem cells. Although researchs in this field has progressed,
their use is somewhat limited due to ethical problems and possible formation of teratoma.
In this paper, we reviewed methods used of stem cells for the treatment of neurological
disorders.</abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol12_nospl_edn1/stem-cell-based-therapy-in-human-neurodegenerative-diseases/</fullTextUrl>



      <keywords language="eng">
        <keyword>Cell Therapy; Neurological Diseases; Embryonic Stem Cells; Ipscs; Teratoma</keyword>
      </keywords>

  </record>
</records>